Bukit Uluwatu Villa Tbk vs Merck Tbk. — how do they compare? Bukit Uluwatu Villa Tbk trades at Rp840 (market cap 20.92T, 23.38M 24h volume), while Merck Tbk. trades at Rp3,830 (market cap 1.7T, 13.3K 24h volume). The key difference: Bukit Uluwatu Villa Tbk is far larger — about 12.3× Merck Tbk.'s market cap, and Bukit Uluwatu Villa Tbk is more actively traded (23.38M versus 13.3K). Which is the better fit depends on your goals.
| BUVA | MERK | |
|---|---|---|
Market Cap | 20.92T | 1.7T |
Volume | 23.38M | 13.3K |
Lot | 233.78K | 133 |
Turnover | 19.67B | 50.92M |
Average Price | 841.32 | 3,828.42 |
Value | 19.67B | 50.92M |
Indicative Equilibrium Price | 850 | 3,850 |
Indicative Equilibrium Volume | 738.8K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bukit Uluwatu Villa Tbk (the “Company”) was established in the Republic of Indonesia on December 15, 2000 based on the Notarial Deed No. 53 of Sugito Tedjamulja, S.H.. The Company’s status has been changed from foreign investment company (PMA) to domestic investment company (PMDN).
Read more on BUVA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →